DS

Durjay Shankar Singh

Director Director DIN 03602504
DIN 03602504 First appointment Sep 2011 Primary industry Trading
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Sep 2011
Shareholding value β€’β€’β€’β€’ Premium profile

About Durjay Shankar Singh

Data last updated:

Durjay Shankar Singh was a Director at Devout Pharmaceuticals Private Limited (2015–2019) and Director at Oripharm Pharma Private Limited (from 2011). The companies operate in Trading.

DIN 03602504
Primary Designation Director
Industry Trading
First Appointment 20 Sep 2011
Oldest Company Age 15 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director30 Nov 20152012₹1.1 Lakh (FY 2025)Active
Oripharm Pharma Private Limited U52310BR2011PTC017498
Director20 Sep 20112011Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Oripharm Pharma Private Limited
Devout Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Durjay Shankar Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Durjay Shankar Singh

Durjay Shankar Singh was first appointed on 20 Sep 2011 as Director at Oripharm Pharma Private Limited. The most recent appointment on record is 30 Nov 2015 at Devout Pharmaceuticals Private Limited.

Durjay Shankar Singh held 2 earlier board appointments: Devout Pharmaceuticals Private Limited (Director, 30 Nov 2015 to 19 Mar 2019); Oripharm Pharma Private Limited (Director, from 20 Sep 2011).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available